Tetra Therapeutics Email Format

Pharmaceutical ManufacturingMichigan, United States11-50 Employees

Tetra Therapeutics is clinical stage biotechnology company developing medicines for Alzheimer's Disease, Fragile X syndrome, Traumatic Brain Injury, major depression and schizophrenia.  The drugs in our pipeline offer a new mechanism focused on PDE4B and PDE4D.

Tetra designs drugs to treat memory loss and cognitive impairment by improving how the brain processes and stores information.

Tetra's promising drug for Alzheimer's Disease, BPN-14770, is being developed in partnership with the NIH Blueprint Therapeutics program.  Our PDE4B platform addresses neuroinflammation, progressive multiple sclerosis (MS), and chronic traumatic encephalopathy (CTE).

✕

Access Insights for Tetra Therapeutics and Millions of Other Companies

Sign up for full access to Tetra Therapeutics information.

Continue with GoogleContinue with Microsoft

No credit card needed

OR

Work email

Create AccountBy creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Sign up for free to view info

Company overview Employee directory